HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperglycemia-induced miR182-5p drives glycolytic and angiogenic response in Proliferative Diabetic Retinopathy and RPE cells via depleting FoxO1.

AbstractPURPOSE:
Diabetic Retinopathy (DR) is associated with metabolic dysfunction in cells such as retinal pigmented epithelium (RPE). Small molecular weight microRNAs can simultaneously regulate multiple gene products thus having pivotal roles in disease pathogenesis. Since miR182-5p is involved in regulating glycolysis and angiogenesis, two pathologic processes of DR, we investigated its status in DR eyes and in high glucose model in vitro.
METHOD:
ology: Total RNA was extracted from vitreous humor of PDR (n = 48) and macular hole (n = 22) subjects followed by quantification of miR182-5p and its target genes. ARPE-19 cells, cultured in DMEM under differential glucose conditions (5 mM and 25 mM) were used for metabolic and biochemical assays. Cells were transfected with miRNA182 mimic or antagomir to evaluate the gain and loss of function effects.
RESULTS:
PDR patient eyes had high levels of miR182-5p levels (p < 0.05). RPE cells under high glucose stress elevated miR182-5p expression with altered glycolytic pathway drivers such as HK2, PFKP and PKM2 over extended durations. Additionally, RPE cells under high glucose conditions exhibited reduced FoxO1 and enhanced Akt activation. RPE cells transfected with miR182-5p mimic phenocopied the enhanced basal and compensatory glycolytic rates observed under high glucose conditions with increased VEGF secretion. Conversely, inhibiting miR182-5p reduced Akt activation, glycolytic pathway proteins, and VEGF while stabilizing FoxO1.
CONCLUSION:
Glycolysis-associated proteins downstream of the FoxO1-Akt axis were regulated by miR182-5p. Further, miR182-5p increased expression of VEGFR2 and VEGF levels, likely via inhibition of ZNF24. Thus, the FoxO1-Akt-glycolysis/VEGF pathway driving metabolic dysfunction with concurrent angiogenic signaling in PDR may be potentially targeted for treatment via miR182-5p modulation.
AuthorsShaika Shanbagh, Santosh Gopikrishna Gadde, Rohit Shetty, Stephane Heymans, V G Abilash, Shyam S Chaurasia, Arkasubhra Ghosh
JournalExperimental eye research (Exp Eye Res) Vol. 238 Pg. 109713 (01 2024) ISSN: 1096-0007 [Electronic] England
PMID37952722 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2023 Elsevier Ltd. All rights reserved.
Chemical References
  • Glucose
  • MicroRNAs
  • Mirn182 microRNA, human
  • Proto-Oncogene Proteins c-akt
  • Vascular Endothelial Growth Factor A
  • FOXO1 protein, human
Topics
  • Humans
  • Diabetes Mellitus
  • Diabetic Retinopathy (metabolism)
  • Glucose (pharmacology)
  • Hyperglycemia
  • MicroRNAs (genetics, metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: